Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDialight Regulatory News (DIA)

Share Price Information for Dialight (DIA)

Share Price is delayed by 15 minutes
Get Live Data
381.00    8.00 (2.14%)
Bid:
379.00
Ask:
400.00
Spread: 21.00 (5.541%)
Market Cap: £152.30m
DIA Live PriceLast checked at - London Stock Exchange

Intraday Dialight Share Chart

Director/PDMR Shareholding

6 Mar 2019 07:00

RNS Number : 9517R
Dialight PLC
05 March 2019
 

Dialight plc (Company)

 

Director/PDMR Shareholdings

5 March 2019

 

Options and Awards under the Dialight plc 2014 Performance Share Plan (PSP)

 

On 5 March 2019, the under mentioned Directors/Persons Discharging Managerial Responsibility, were granted nil cost options that entitled each of them to receive ordinary shares of 1.89 pence each in the Company in accordance with the rules of the PSP:

 

Name

Number of Options granted under the PSP

Total number of shares over which incentive awards in the PSP held following notification

% of issued class

Fariyal Khanbabi

(Director)

68,803

196,685

0.604

Richard Allan

12,503

12,503

0.038

Gary Ashburner

10,002

10,002

0.031

 

On 5 March 2019, the under mentioned Directors/Persons Discharging Managerial Responsibility, were granted conditional awards that entitled them to acquire ordinary shares of 1.89 pence each in the Company in accordance with the rules of the PSP:

 

Name

Number of shares awarded under the PSP

Total number of shares over which incentive awards in the PSP held following notification

% of issued class

Martin Rapp

(Director)

145,011

249,291

0.766

Luis Ramirez

29,425

54,193

0.167

Sri Talpallikar

11,153

11,153

0.034

Rizwan Ahmad

10,291

28,303

0.087

Aziz Rahman

9,966

9,966

0.031

Matt Boudiette

21,215

40,959

0.126

Tim Cillessen

10,530

14,851

0.046

 

Options and awards will normally vest on the third anniversary of grant subject to continued employment. In relation to the awards made to Martin L. Rapp and Fariyal Khanbabi only, the award and options (respectively) are subject to the satisfaction of two performance conditions as set out below.

25% of the option or award is measured against the Company's total shareholder return (TSR) over the three year period relative to the FTSE SmallCap Index (excluding investment trusts) (TSR Performance Condition). The remaining 75% of the option or award is measured against the Company's earnings per share (EPS) in 2021 (EPS Performance Condition).

TSR Performance Condition

No part of an option or award subject to the TSR Performance Condition shall vest if the percentage change in the Company's TSR is below the percentage change in the TSR of the comparator index. 25% of the ordinary shares subject to the TSR Performance Condition will vest if the percentage change in the Company's TSR is equal to the percentage change in the TSR of the comparator index, rising on a straight-line basis, to 100% vesting if the percentage change in the Company's TSR is equal to the change in the TSR of the index plus 10% per annum.

EPS Performance Condition

No part of an option or award subject to the EPS Performance Condition will vest if the Company's 2021 EPS is below 40p, 25% of the ordinary shares subject to the EPS Option/Award will vest if the Company's 2021 EPS reaches 40p, rising on a straight-line basis, to 100% vesting if the Company's 2021 EPS exceeds 60p.

No consideration was paid for the grant of these options and awards and no consideration is due to be paid by the participant on the vesting of these options and awards. On vesting options will be exercisable between 5 March 2022 and 5 March 2024.

Holding Period

A mandatory two-year post-vesting holding period applies to the PSP options/awards granted to Martin L. Rapp and Fariyal Khanbabi.

 

The details of the awards and options are as follows:

 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

i. Martin L. Rapp

ii. Fariyal Khanbabi

iii. Richard Allan

iv. Luis Ramirez

v. Sri Talpallikar

vi. Rizwan Ahmad

vii. Aziz Rahman

viii. Matt Boudiette

ix. Gary Ashburner

x. Tim Cillessen

2.

Reason for the notification

(a)

Position / status

i. Group Chief Executive

ii. Group Finance Director

iii. Group General Counsel

iv. Chief Operating Officer

v. VP, Sales and Marketing

vi. VP, Technology

vii. VP, Engineering

viii. VP, Signals / Components / Obstruction / Wind

ix. VP, Sales - Americas

x. VP / GM EMEA

(b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

(a)

Name

Dialight plc

(b)

LEI

2138001AD31KKD29Z495

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.0189 each

(b)

Identification code of the Financial Instrument

GB0033057794

(c)

Nature of the transaction

Grant of share options/awards under the Dialight plc PSP equity scheme

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

i. Nil

ii. Nil

iii. Nil

iv. Nil

v. Nil

vi. Nil

vii. Nil

viii. Nil

ix. Nil

x. Nil

i. 145,011

ii. 68,803

iii. 12,503

iv. 29,425

v. 11,153

vi. 10,291

vii. 9,966

viii. 21,215

ix. 10,002

x. 10,530

(e)

Aggregated information

- Aggregated volume

- Price

 

328,899 awards and options

Nil

(f)

Date of the transaction

5 March 2019

(g)

Place of the transaction

Outside a trading venue

 

This announcement is made in accordance with Article 19.3 of the Market Abuse Regulation.

 

Richard Allan

General Counsel

Tel: +44 (0) 203 058 3546

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUGUUCWUPBPUA
Date   Source Headline
2nd Jun 20267:00 amRNSNotice of Results & Investor Presentation
28th May 20267:00 amRNSHolding(s) in Company
26th May 20267:00 amRNSHolding(s) in Company
13th May 202612:52 pmRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights and Admission of Shares
1st Apr 20269:54 amRNSTransaction in Own Shares
30th Mar 20263:43 pmRNSDirector/PDMR Shareholding
25th Mar 20269:32 amRNSDirector/PDMR Shareholding
16th Mar 202610:41 amRNSIssue of Equity and Total Voting Rights
16th Mar 202610:41 amRNSIssue of Equity and Total Voting Rights
26th Feb 20266:32 pmRNSHolding(s) in Company
8th Jan 20267:00 amRNSThird Quarter Trading Update
12th Nov 20259:33 amRNSInvestor Presentation via Investor Meet Company
11th Nov 20254:55 pmRNSDirector/PDMR Shareholding
11th Nov 20257:00 amRNSFY26 Interim Results
6th Oct 20257:00 amRNSTrading Statement
30th Sep 20257:00 amRNSBlock listing Interim Review
16th Sep 20259:39 amRNSTotal Voting Rights
3rd Sep 20251:24 pmRNSHolding(s) in Company
2nd Sep 20253:34 pmRNSResult of AGM - Addendum
1st Sep 20253:21 pmRNSResult of AGM
1st Sep 20257:00 amRNSTrading Statement
14th Aug 20251:05 pmRNSHolding(s) in Company
11th Aug 202512:58 pmRNSHolding(s) in Company
1st Aug 20255:57 pmRNSHolding(s) in Company
1st Aug 20255:54 pmRNSHolding(s) in Company
1st Aug 20255:47 pmRNSHolding(s) in Company
1st Aug 20251:33 pmRNSHolding(s) in Company
14th Jul 20252:04 pmRNSNotice of AGM
14th Jul 202510:05 amRNSAnnual Financial Report
4th Jul 20257:00 amRNSDirector/PDMR Shareholding
3rd Jul 202510:18 amRNSDirector/PDMR Shareholding
24th Jun 202512:53 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
1st May 20254:04 pmRNSDirectorate Change
7th Apr 20254:50 pmRNSTotal Voting Rights
7th Apr 20254:44 pmRNSBlock listing Interim Review
31st Mar 20257:00 amRNSSanmina Final Agreement, Trading update
20th Mar 20255:49 pmRNSApplication for Block Listing
20th Mar 20257:00 amRNSDirector Declaration
19th Mar 20253:37 pmRNSDirector/PDMR Shareholding
18th Mar 20255:17 pmRNSDirector/PDMR Shareholding
14th Mar 20252:42 pmRNSHolding(s) in Company
4th Feb 20257:30 amRNSDirector Declaration
4th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 20257:00 amRNSTrading Statement
10th Dec 20247:00 amRNSDirectorate Change
25th Nov 20247:00 amRNSHalf-year Report
11th Nov 20247:00 amRNSDirectorate Change
4th Nov 20242:03 pmRNSDate of half-year results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.